CRISPR Therapeutics AG

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 202
EBIT TTM (mln): -332
index 0 1 2 3 4 5 6 7 8 9 10
Rok finansowy 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 5 41 3 290 1 913 0 370 35
Przychód Δ r/r 0.0% inf% 1990.7% 693.9% -92.4% 9169.8% -99.8% 168054.9% -100.0% 84762.4% -90.5%
Marża brutto 0.0% 100.0% 100.0% 100.0% 100.0% 38.1% -49514.5% 98.0% -25186.7% 64.8% 106.6%
EBIT (mln) -7 -26 -68 -65 -159 47 -354 374 -673 -223 -467
EBIT Δ r/r 0.0% 288.2% 164.8% -5.1% 145.9% -129.4% -858.3% -205.4% -280.2% -66.9% 109.7%
EBIT (%) 0.0% -10416.6% -1319.3% -157.7% -5087.8% 16.1% -65273.5% 40.9% -154394.7% -60.1% -1333.0%
Koszty finansowe (mln) 0 0 8 0 0 0 0 0 -47 0 0
EBITDA (mln) -7 -26 -25 -62 -159 47 -345 374 -673 -203 -467
EBITDA(%) 0.0% -10358.7% -488.5% -150.3% -5087.8% 16.1% -63582.1% 40.9% -154394.7% -54.8% -1333.0%
Podatek (mln) -0 0 0 2 1 0 1 2 -0 3 4
Zysk Netto (mln) -7 -26 -23 -68 -165 67 -349 378 -650 -154 -366
Zysk netto Δ r/r 0.0% 279.8% -10.2% 194.6% 141.4% -140.5% -621.8% -208.3% -272.2% -76.4% 138.4%
Zysk netto (%) 0.0% -10456.7% -449.3% -166.7% -5281.1% 23.1% -64247.7% 41.4% -149122.7% -41.5% -1046.4%
EPS -0.23 -0.88 -1.89 -1.71 -3.44 1.23 -5.29 4.97 -8.36 -1.94 -4.34
EPS (rozwodnione) -0.23 -0.88 -1.89 -1.71 -3.44 1.17 -5.29 4.7 -8.36 -1.94 -4.34
Ilośc akcji (mln) 29 29 12 40 48 54 66 76 78 79 84
Ważona ilośc akcji (mln) 29 29 12 40 48 57 66 80 78 79 84
Waluta USD USD USD USD USD USD USD USD USD USD USD